JP2012510499A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012510499A5 JP2012510499A5 JP2011538991A JP2011538991A JP2012510499A5 JP 2012510499 A5 JP2012510499 A5 JP 2012510499A5 JP 2011538991 A JP2011538991 A JP 2011538991A JP 2011538991 A JP2011538991 A JP 2011538991A JP 2012510499 A5 JP2012510499 A5 JP 2012510499A5
- Authority
- JP
- Japan
- Prior art keywords
- vivo
- contrast agent
- synuclein
- imaging moiety
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000001727 in vivo Methods 0.000 claims 17
- 239000002872 contrast media Substances 0.000 claims 16
- 238000011503 in vivo imaging Methods 0.000 claims 12
- 102000003802 alpha-Synuclein Human genes 0.000 claims 8
- 108090000185 alpha-Synuclein Proteins 0.000 claims 8
- 229910052739 hydrogen Inorganic materials 0.000 claims 8
- 238000000034 method Methods 0.000 claims 8
- 239000001257 hydrogen Substances 0.000 claims 7
- 125000000217 alkyl group Chemical group 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 4
- 239000012453 solvate Substances 0.000 claims 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 3
- 208000018737 Parkinson disease Diseases 0.000 claims 3
- 239000011230 binding agent Substances 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 3
- 125000005843 halogen group Chemical group 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 230000002285 radioactive effect Effects 0.000 claims 3
- 241000124008 Mammalia Species 0.000 claims 2
- 125000004103 aminoalkyl group Chemical group 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 2
- 210000003403 autonomic nervous system Anatomy 0.000 claims 2
- 125000001188 haloalkyl group Chemical group 0.000 claims 2
- 125000005842 heteroatom Chemical group 0.000 claims 2
- 150000002431 hydrogen Chemical class 0.000 claims 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 210000004558 lewy body Anatomy 0.000 claims 2
- 229910021645 metal ion Inorganic materials 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- 125000004001 thioalkyl group Chemical group 0.000 claims 2
- 150000003573 thiols Chemical class 0.000 claims 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000000304 alkynyl group Chemical group 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 125000005021 aminoalkenyl group Chemical group 0.000 claims 1
- 125000002431 aminoalkoxy group Chemical group 0.000 claims 1
- 125000005014 aminoalkynyl group Chemical group 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 125000004181 carboxyalkyl group Chemical group 0.000 claims 1
- 150000001768 cations Chemical group 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 125000005159 cyanoalkoxy group Chemical group 0.000 claims 1
- 125000004966 cyanoalkyl group Chemical group 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 238000013399 early diagnosis Methods 0.000 claims 1
- 210000000105 enteric nervous system Anatomy 0.000 claims 1
- 125000000262 haloalkenyl group Chemical group 0.000 claims 1
- 125000004438 haloalkoxy group Chemical group 0.000 claims 1
- 125000000232 haloalkynyl group Chemical group 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 125000005020 hydroxyalkenyl group Chemical group 0.000 claims 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 1
- 125000005016 hydroxyalkynyl group Chemical group 0.000 claims 1
- 239000012216 imaging agent Substances 0.000 claims 1
- 210000002241 neurite Anatomy 0.000 claims 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 1
- 125000004971 nitroalkyl group Chemical group 0.000 claims 1
- 229910052755 nonmetal Inorganic materials 0.000 claims 1
- 238000012634 optical imaging Methods 0.000 claims 1
- 230000005298 paramagnetic effect Effects 0.000 claims 1
- 229910052700 potassium Inorganic materials 0.000 claims 1
- 239000011591 potassium Substances 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- 125000005309 thioalkoxy group Chemical group 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11906008P | 2008-12-02 | 2008-12-02 | |
| GB0821994.1 | 2008-12-02 | ||
| GBGB0821994.1A GB0821994D0 (en) | 2008-12-02 | 2008-12-02 | In viva imaging method |
| US61/119,060 | 2008-12-02 | ||
| PCT/EP2009/066120 WO2010063701A2 (en) | 2008-12-02 | 2009-12-01 | In vivo imaging method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012510499A JP2012510499A (ja) | 2012-05-10 |
| JP2012510499A5 true JP2012510499A5 (OSRAM) | 2012-12-27 |
Family
ID=40262535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011538991A Withdrawn JP2012510499A (ja) | 2008-12-02 | 2009-12-01 | 生体内イメージング法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20110236307A1 (OSRAM) |
| EP (1) | EP2389200A2 (OSRAM) |
| JP (1) | JP2012510499A (OSRAM) |
| CN (1) | CN102300589A (OSRAM) |
| GB (1) | GB0821994D0 (OSRAM) |
| WO (1) | WO2010063701A2 (OSRAM) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101297815B1 (ko) * | 2010-11-18 | 2013-09-03 | 충남대학교산학협력단 | 폴리감마글루탐산과 광학영상다이의 복합체를 함유하는 센티넬 림프노드 감지용 광학영상 프로브 |
| KR102563040B1 (ko) | 2014-06-25 | 2023-08-02 | 뉴카나 피엘씨 | 젬시타빈 전구 약물 |
| KR20240036709A (ko) | 2016-03-11 | 2024-03-20 | 에이씨 이뮨 에스에이 | 진단 및 치료를 위한 바이사이클릭 화합물 |
| EP3562306B1 (en) | 2016-12-29 | 2025-02-26 | Ji Xing Pharmaceuticals Hong Kong Limited | Metalloenzyme inhibitor compounds |
| EP3562487B1 (en) | 2016-12-29 | 2023-11-29 | Ji Xing Pharmaceuticals Hong Kong Limited | Metalloenzyme inhibitor compounds |
| MX2021011775A (es) | 2017-04-26 | 2023-01-10 | Basilea Pharm Int Ag | Procesos para la preparacion de furazanobencimidazoles y formas cristalinas de estos. |
| CN112105393A (zh) * | 2018-05-16 | 2020-12-18 | 爱默蕾大学 | 苯乙烯基苯并噻唑衍生物及在成像中的用途 |
| ES2988770T3 (es) | 2018-06-08 | 2024-11-21 | Ac Immune Sa | Nuevos compuestos para diagnóstico |
| WO2020056064A1 (en) | 2018-09-11 | 2020-03-19 | Stanley Satz | Tumor targeted radionuclide therapy and molecular imaging of her2+ cancers and other neoplasms, and precision medicine. |
| CN114269383A (zh) | 2019-01-08 | 2022-04-01 | 菲斯生物制药公司 | 金属酶抑制剂化合物 |
| CA3175602A1 (en) | 2020-05-07 | 2021-11-11 | Jerome Molette | Novel compounds for diagnosis |
| WO2023084000A1 (en) | 2021-11-10 | 2023-05-19 | Ac Immune Sa | 4h-imidazo[1,5-b]pyrazole derivatives for diagnosis |
| EP4430044A1 (en) | 2021-11-10 | 2024-09-18 | AC Immune SA | Dihydropyrrolo[3,4-c]pyrazole derivatives and their use in diagnosis |
| US20250034149A1 (en) | 2021-11-10 | 2025-01-30 | Ac Immune Sa | Dihydropyrrolo[3,4c]-pyrazole derivatives and their use in diagnosis |
| EP4634191A1 (en) | 2022-12-16 | 2025-10-22 | AC Immune SA | Novel compounds for diagnosis |
| JP2026500311A (ja) | 2022-12-16 | 2026-01-06 | エーシー・イミューン・エス・アー | 診断のための新規化合物 |
| EP4733299A1 (en) | 2023-05-22 | 2026-04-29 | Shenzhen Braegen Pharmaceutical Co., Ltd. | Sulfur-containing fused ring compound, pharmaceutical composition containing same, and preparation method therefor and use thereof |
| WO2025037013A1 (en) | 2023-08-16 | 2025-02-20 | Ac Immune Sa | Diagnostic compounds that bind to alpha-synuclein |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010047032A1 (en) * | 1999-12-30 | 2001-11-29 | Castillo Gerardo M. | Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases |
| US6379650B1 (en) * | 2001-03-19 | 2002-04-30 | Wesley Scott Ashton | Technetium 99m-N2S2-congo red complexes utilizing diamide dithiolate ligand systems for radioimaging |
| US7521481B2 (en) * | 2003-02-27 | 2009-04-21 | Mclaurin Joanne | Methods of preventing, treating and diagnosing disorders of protein aggregation |
| US8329142B2 (en) * | 2003-05-29 | 2012-12-11 | Pettegrew Jay W | Compounds, compositions and methods for medical imaging of Parkinson's disease |
| WO2007011834A2 (en) * | 2005-07-15 | 2007-01-25 | The Regents Of The University Of California | Compounds and method for the diagnosis and treatment of amyloid associated diseases |
| AU2006320556A1 (en) * | 2005-12-01 | 2007-06-07 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Isotopically-labeled benzothiazole compounds as imaging agents for amyloidogenic proteins |
| WO2008060364A2 (en) * | 2006-10-02 | 2008-05-22 | Ac Immune S.A | Humani zed antibody against amyloid beta |
| WO2008030973A2 (en) * | 2006-09-06 | 2008-03-13 | The Board Of Regents Of The University Of Texas System | Methods and compositions for the detection of protein folding disorders |
| WO2008121407A1 (en) * | 2007-03-30 | 2008-10-09 | The Regents Of The University Of California | In vivo imaging of sulfotransferases |
-
2008
- 2008-12-02 GB GBGB0821994.1A patent/GB0821994D0/en not_active Ceased
-
2009
- 2009-12-01 WO PCT/EP2009/066120 patent/WO2010063701A2/en not_active Ceased
- 2009-12-01 EP EP09768015A patent/EP2389200A2/en not_active Withdrawn
- 2009-12-01 JP JP2011538991A patent/JP2012510499A/ja not_active Withdrawn
- 2009-12-01 US US13/132,109 patent/US20110236307A1/en not_active Abandoned
- 2009-12-01 CN CN2009801562662A patent/CN102300589A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6722663B2 (ja) | マクロファージおよび他のマンノース結合ｃ型レクチン受容体高発現細胞を標的化するための化合物および組成物、ならびにそれらを使用して治療するおよび診断する方法 | |
| US20250228985A1 (en) | Compounds and compositions for targeting macrophages and other mannose-binding c-type lectin receptor high expressing cells and methods of treating and diagnosis using same | |
| CA2955441C (en) | Dextran conjugates for targeting macrophages and other cd296-expressing cells | |
| JP6607854B2 (ja) | Ｃｄ２０６発現細胞関連障害を診断および処置するための組成物、方法およびキット | |
| Lee et al. | Prostate cancer-targeted imaging using magnetofluorescent polymeric nanoparticles functionalized with bombesin | |
| Wang et al. | Radioligand therapy of prostate cancer with a long-lasting prostate-specific membrane antigen targeting agent 90Y-DOTA-EB-MCG | |
| JP2007501862A5 (OSRAM) | ||
| US20250339405A1 (en) | a-SYNUCLEIN AGGREGATE BINDING AGENT AND IMAGING METHOD | |
| ATE529425T1 (de) | Verbindungen mit affinität zu amyloid | |
| Xu et al. | Design, synthesis, and in vitro and in vivo evaluation of high affinity and specificity near-infrared fluorescent bombesin antagonists for tumor imaging | |
| EP2291075A4 (en) | GASTRIN RELEASING PEPTIDE COMPOUNDS | |
| RU2008147002A (ru) | Новые соединения, обладающие сродством к амилоиду | |
| CN111447955A (zh) | 99mTc-替马诺塞和相关的分子构建体用于鉴定和诊断恶性肿瘤和用于监测治疗性抗肿瘤干预的用途 | |
| US10806803B2 (en) | Compositions for targeting macrophages and other CD206 high expressing cells and methods of treating and diagnosis | |
| DK2776382T3 (en) | 18F saccharide-folates | |
| JP5425181B2 (ja) | 蛍光ｍｒｉプローブ | |
| Bhojani et al. | Synthesis and investigation of a radioiodinated F3 peptide analog as a SPECT tumor imaging radioligand | |
| US20170202969A1 (en) | Compounds and compositions for targeting macrophages and other mannose-binding c-type lectin receptor high expressing cells and methods of treating and diagnosis using same | |
| WO2013138612A1 (en) | Synthesis and application of novel imaging agents conjugated to dpa 713 analogs for imaging inflammation | |
| Chen et al. | Preclinical Evaluation and First-in-Human PET Study of Al18F-Labeled Biphenyl-Based Dimeric PSMA Tracers | |
| JP2013507345A5 (OSRAM) | ||
| JP2023134629A (ja) | 高いｉｎ ｖｉｖｏ ＮＭＤ特異性を有するベンザゼピン－１，７－ジオールから誘導される放射性標識リガンド | |
| Ferro-Flores et al. | Synthesis and Evaluation of [18F] AlF-NOTA-iPD-L1 as a Potential Theranostic Pair for [177Lu] Lu-DOTA-iPD-L1 | |
| US12070504B1 (en) | Compounds and methods for altering cyto-states of cells that express c-type lectin receptors |